Articles Posted in Roundup News

Accusations Fly in Roundup™ Appeal

As the class-action lawsuit against Bayer moves along, lawyers for the plaintiffs are accusing the company of a “Pay to Appeal” scheme. According to the plaintiffs’ lawyers’ letter to the court, the strategy by Bayer is to obtain a favorable ruling, which the attorneys say is manufactured and could erode the U.S. justice system if it is permitted.

In Wake of Lawsuits, Bayer Chairman Retires

The chairman of Bayer, Werner Wenning, who supported the takeover of Monsanto, the producer of Roundup®, has announced he is stepping down. Bayer, which produces pesticides and pharmaceutical products, purchased Monsanto back in 2016, paying over $60 billion for the company. With continued lawsuits against the company because of the weedkiller Roundup® and its link to cancer, company shares went into a steep dive since August 2018. This was when Bayer lost its first Roundup® cancer lawsuit in the United States.

Did Bayer Offer an $8 Billion Roundup™ Settlement?

On Friday, August 9, it was reported that Bayer offered to settle Roundup™ cases for $8 billion. This news was beneficial for Bayer’s corporate bottom line after a stock market rally on the same day sent the price of shares edging up by 11 percent. It was good news for the company since shares have fallen since the Bayer takeover of Monsanto 14 months ago. The supposed settlement involved roughly 18,000 claims against the company’s herbicide in the United States. Plaintiffs’ lawyers asked for a larger settlement at about $10 billion dollars. When queried about whether the company had anything to say about the settlement, Bayer remained ominously quiet. A Bayer representative, Tino Andresen, refused to comment. A mediator assigned by the courts to work out a settlement, Ken Feinberg, said that the report of a settlement was fiction. 

Merril Hoge, ESPN Announcer and NFL Player, Sues Monsanto

Merril Hoge, an NFL player and an analyst for ESPN, has filed a lawsuit against Monsanto in federal court, the company that manufactures the weed killer Roundup™. Hoge, 54, was diagnosed with non-Hodgkin’s lymphoma in 2003. His lawyer said Hoge, who played for the Pittsburgh Steelers, worked on farms throughout his life in his native Pocatello, Idaho. Hoge mixed and used Roundup™ on a weekly basis, according to the federal claim. The lawsuit was filed in an Idaho district court on July 3, 2019. Hoge’s claim says that he incurred significant non-economic and economic damages due to the effects of exposure to glyphosate. He was treated for non-Hodgkin’s lymphoma and has since been in remission for 16 years. 

New Rulings in Hardeman Roundup™ Case

Monsanto/Bayer’s request for a new trial was denied in the Edward Hardeman case on July 12. This request centered on the evidence Hardeman’s attorneys used in the trial to prove that Roundup™ was the causative agent of Hardeman’s cancer. The defendant disputed the evidence, insisting that there were other mitigating circumstances such as Hepatitis C, which Hardeman had in the past. The company said it was not surprised by this ruling. U.S. District Court Judge Vince Chhabria said that the evidence presented at trial was both admissible and sufficient to prove the plaintiff’s case. A second ruling is expected on the 15th, and Monsanto/Bayer said it will not evaluate its options until both rulings are heard.

Roundup Lawsuits

Roundup is a yard agent commonly used to kill weeds. Unfortunately, this chemical can also lead to harmful health effects. Manufactured by Monsanto, many individuals have developed a form of cancer called Non-Hodgkin’s Lymphoma after being exposed to this chemical. This is an aggressive disease that could lead to chemotherapy, surgery, permanent health complications, or even death. Unfortunately, Monsanto knew about these risks and failed to warn its consumers or the public as a whole. Fortunately, Monsanto is being held accountable for its inaction by a Monsanto Roundup Cancer Attorney, giving hope to all of those afflicted by Roundup and Monsanto.

Roundup™ Causes More Than Non-Hodgkin’s Lymphoma

In the recent past, reports have linked Roundup™ to non-Hodgkin’s lymphoma. The association of the herbicide and this form of cancer has been documented repeatedly. Yet, the use of glyphosate is linked to numerous other health issues. This is bad news for gardeners, farmers, groundskeepers, and homeowners. The number of disorders is large and varied. Let’s look at new research that examines the popular weed killer from this perspective.

Next Monsanto Trial Begins in August

The next Roundup™ Monsanto trial is slated for August 19 in St. Louis County Court, several miles from the corporation’s campus. The fact that it is in Monsanto’s hometown is important. Here, corporate executives can be ordered to appear at trial and testify. This is the first case for Monsanto outside of California. It is also the first case after the stunning $2 billion loss to a California couple in a Monsanto trial. They claimed that they developed non-Hodgkin’s lymphoma after using Roundup™ for 30 years. That was the eighth largest amount ever to be awarded in a defective product case.

Roundup™ Lawsuit Nets Over $2.5 Billion Verdict  

The latest verdict in a Roundup™ lawsuit against Monsanto of more than $2.5 billion is the biggest yet. A jury in Alameda County agreed with the plaintiff’s attorney that Roundup™ caused Alva and Alberta Pilliod to develop non-Hodgkin’s lymphoma. The couple, who reside in Livermore, California, were exposed to glyphosate for decades. After 17 days of testimony and two days of deliberations, the jury handed down their verdict. Bayer announced that it was disappointed with the jury’s conclusion and said they would appeal. They called the verdict in this Roundup™ lawsuit unjustifiable and excessive. Bayer went on to say that both plaintiffs suffered from past illnesses that could lead to the development of this type of lymphoma.

Mediation Order Issued by Judge in Monsanto Cases

U.S. District Judge Vince Chhabria issued a formal mediation order to Monsanto/Bayer and plaintiff attorneys on April 12. Mediation is a valuable tool in many court cases. The goal here is to reach a settlement between Monsanto/Bayer and those who developed cancer from Roundup™. Lawyers will represent greater than 1,000 individuals in the settlement talks. In his order, Chhabria said that both sides could propose a mediator. If they can’t agree on one, the court will appoint a mediator.  

Contact Information